港股创新药板块多数走低，晶泰控股(02228.HK)跌超4%，亚盛医药(06855.HK)跌超3%，药明康德(02359.HK)、四环医药(00460.HK)等跟跌。

Group 1 - The Hong Kong innovative drug sector experienced a decline, with several companies showing significant drops in stock prices [1] - Crystal Technology Holdings (02228.HK) fell over 4%, indicating a notable decrease in investor confidence [1] - Ascentage Pharma (06855.HK) also saw a decline of more than 3%, alongside other companies like WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) which followed suit [1]